Fausto Carmona loses $4.5 million in guaranteed salary for 2012

1 Comment

Jon Heyman of CBSSports.com recently reported that the Indians restructured the contract of Roberto Hernandez, formerly known as Fausto Carmona, following his arrest on false identity charges in January. Now we know the details.

According to the Associated Press, Hernandez will make $2.5 million as a base salary in 2012 and can earn an additional $2.7 million in performance and roster bonuses. He was previously set to earn $7 million this season after the Indians picked up his club option in October. His $9 million option for 2013 was also reduced to $6 million, but he has a chance to make an additional $3 million in bonuses based on innings pitched.

Of course, Hernandez won’t earn a dime until he is removed from MLB’s restricted list. He recently reached a deal to have his false identity charges dropped in exchange for completing a work program in his native Dominican Republic, but he is currently awaiting a work visa to return to the United States.

MLB, union resume blood testing after pandemic, lockout

Scott Taetsch-USA TODAY Sports
1 Comment

NEW YORK – In the first acknowledgment that MLB and the players’ association resumed blood testing for human growth hormone, the organizations said none of the 1,027 samples taken during the 2022 season tested positive.

HGH testing stopped in 2021 because of the COVID-19 pandemic. Testing also was halted during the 99-day lockout that ended in mid-March, and there were supply chain issues due to COVID-19 and additional caution in testing due to coronavirus protocols.

The annual public report is issued by Thomas M. Martin, independent program administrator of MLB’s joint drug prevention and treatment program. In an announcement accompanying Thursday’s report, MLB and the union said test processing is moving form the INRS Laboratory in Quebec, Canada, to the UCLA Laboratory in California.

MLB tests for HGH using dried blood spot testing, which was a change that was agreed to during bargaining last winter. There were far fewer samples taken in 2022 compared to 2019, when there were 2,287 samples were collected – none positive.

Beyond HGH testing, 9,011 urine samples were collected in the year ending with the 2022 World Series, up from 8,436 in the previous year but down from 9,332 in 2019. And therapeutic use exemptions for attention deficit hyperactivity disorder dropped for the ninth straight year, with just 72 exemptions in 2022.

Overall, the league issued six suspensions in 2022 for performance-enhancing substances: three for Boldenone (outfielder/first baseman Danny Santana, pitcher Richard Rodriguez and infielder Jose Rondon, all free agents, for 80 games apiece); one each for Clomiphene (Milwaukee catcher Pedro Severino for 80 games), Clostebol (San Diego shortstop Fernando Tatis Jr. for 80 games) and Stanozolol (Milwaukee pitcher J.C. Mejia for 80 games).

There was an additional positive test for the banned stimulant Clobenzorex. A first positive test for a banned stimulant results in follow-up testing with no suspension.